Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3Brain
Wädenswil, Zurich, Switzerland3brain.com ↗
- Ownership
- Private
- Employees
- ~59
- Development stage
- Commercial
01
Overview
3Brain has developed and commercialized the world’s first CMOS-based high-resolution microelectrode array biosensor, enabling non-invasive in vitro investigations of electrogenic cells such as neurons and cardiac cells. Their technology supports advanced research into brain diseases and drug discovery by providing superior spatial and temporal resolution for cell-based assays[1][2][4].
- Modalities
- DeviceBiosensorIn vitro assay platform (CMOS-based high-density microelectrode array)
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on 3Brain.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3Brain.